p53 Autoantikörper in der klinischen Diagnostik

Literatur

• 1 Chen Y M, Chen, SH, Fu C Y, Chen J Y, Osame M. Antibody reactivities to tumor-suppressor protein p53 and HTLV-I Tof, Rex and Tax in HTLV-I-infected people with differing clinical status.  Int J Cancer. 1997;  71 196
• 2 Green J A, Mudenda B, Jenkins J, Leinster S J, Tarunina M, Green B, Robertson L. Serum p53 auto-antibodies: Incidence in familial breast cancer.  Eur J Cancer [A]. 1994;  30A 580
• 3 Kovacs B, Patel A, Hershey J N, Dennis G J, Kirschfink M, Tsokos G C. Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic diseases.  Arthritis Rheum. 1997;  40 980
• 4 Lane D P. Exploiting the p53 pathway for cancer diagnosis and therapy.  Br J Cancer. 1999;  80 1
• 5 Lubin R, Zalcman G, Bouchet L, Trédaniel J, Legros Y, Cazals D, Hirsch A, Soussi T. Serum p53 antibodies as early markers of lung cancer.  Nature Med. 1995;  1 701
• 6 Malkin D. p53 and the Li-Fraumeni syndrome.  Biochim Biophys Acta Rev Cancer. 1994;  1198 197
• 7 Mariette X, Sibilia J, Delaforge C, Bengoufa D, Brouet J C, Soussi T. Anti-p53 antibodies are rarely detected in serum of patients with rheumatoid arthritis and Sjogren’s syndrome.  J Rheumatol. 1999;  26 1672
• 8 Marxsen J, Schmiegel W, Röder C, Harder R, Juhl H, Henne-Bruns D, Kremer B, Kalthoff H. Detection of the anti-p53 antibody response in malignant and benign pancreatic disease.  Br J Cancer. 1994;  70 1031
• 9 Montenarh M. Humoral response against p53 in human malignancies. 377-394. In: Pathogenic and diagnostic relevance of autoantibodies. Ed. Konrad K, Humbel R-L, Meuer M, Schoenfeld Y, Tan EM. Pabst Science Publishers 1998
• 10 Raedle J, Oremek G, Truschnowitsch, Lorenz M, Roth W K, Caspary W F, Zeuzem S. Clinical evaluation of autoantibodies to p53 protein in patients with chronic liver disease and hepatocellular carcinoma.  Eur J Cancer [A]. 1998;  34 1198
• 11 Ralhan R, Nath N, Agarwal S, Mathur M, Wasylyk B, Shukla N K. Circulating p53 antibodies as early markers of oral cancer: Correlation with p53 alterations.  Clin Cancer Res. 1998;  4 2147
• 12 Soussi T. The humoral response to the tumor-suppressor geneproduct p53 in human cancer: Implications for diagnosis and therapy.  Immunol Today. 1996;  17 354

• 13 Trivers G E, Cawley H L, DeBenedetti V M, Hollstein, M, Marion M J, Bennett W P, Hoover M L, Prives C C, Tamburro C C, Harris C C. Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride.  JNCI. 1995;  87 1400
• 14 Trivers G E, De Benedetti V M-G, Cawley H L, Caron A, Harrington M, Bennett W P, Jett J R, Colby T V, Tazelaar H, Pairolero P, Miller R D, Harris C C. Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.  Clin Cancer Res. 1996;  2 1767

Korrespondenz